TY - JOUR
T1 - Effects of antibiotics on human microbiota and subsequent disease
AU - Keeney, Kristie M.
AU - Yurist-Doutsch, Sophie
AU - Arrieta, Marie Claire
AU - Finlay, B. Brett
N1 - Publisher Copyright:
Copyright © 2014 by Annual Reviews. All rights reserved.
PY - 2014/9/8
Y1 - 2014/9/8
N2 - Although antibiotics have significantly improved human health and life expectancy, their disruption of the existing microbiota has been linked to significant side effects such as antibiotic-associated diarrhea, pseudomembranous colitis, and increased susceptibility to subsequent disease. By using antibiotics to break colonization resistance against Clostridium, Salmonella, and Citrobacter species, researchers are now exploring mechanisms for microbiota-mediated modulation against pathogenic infection, revealing potential roles for different phyla and family members as well as microbiota-liberated sugars, hormones, and short-chain fatty acids in regulating pathogenicity. Furthermore, connections are now being made between microbiota dysbiosis and a variety of different diseases such as rheumatoid arthritis, inflammatory bowel disease, type 1 diabetes, atopy, and obesity. Future advances in the rapidly developing field of microbial bioinformatics will enable researchers to further characterize the mechanisms of microbiota modulation of disease and potentially identify novel therapeutics against disease.
AB - Although antibiotics have significantly improved human health and life expectancy, their disruption of the existing microbiota has been linked to significant side effects such as antibiotic-associated diarrhea, pseudomembranous colitis, and increased susceptibility to subsequent disease. By using antibiotics to break colonization resistance against Clostridium, Salmonella, and Citrobacter species, researchers are now exploring mechanisms for microbiota-mediated modulation against pathogenic infection, revealing potential roles for different phyla and family members as well as microbiota-liberated sugars, hormones, and short-chain fatty acids in regulating pathogenicity. Furthermore, connections are now being made between microbiota dysbiosis and a variety of different diseases such as rheumatoid arthritis, inflammatory bowel disease, type 1 diabetes, atopy, and obesity. Future advances in the rapidly developing field of microbial bioinformatics will enable researchers to further characterize the mechanisms of microbiota modulation of disease and potentially identify novel therapeutics against disease.
KW - Antibiotics
KW - Enteric
KW - Microbiota
KW - Pathogen
UR - http://www.scopus.com/inward/record.url?scp=84907528345&partnerID=8YFLogxK
U2 - 10.1146/annurev-micro-091313-103456
DO - 10.1146/annurev-micro-091313-103456
M3 - Review article
C2 - 24995874
AN - SCOPUS:84907528345
SN - 0066-4227
VL - 68
SP - 217
EP - 235
JO - Annual Review of Microbiology
JF - Annual Review of Microbiology
ER -